The opioid antagonist, β-funaltrexamine, inhibits NF-κB signaling and chemokine expression in human astrocytes and in mice

Research output: Contribution to journalArticle

10 Scopus citations

Fingerprint Dive into the research topics of 'The opioid antagonist, β-funaltrexamine, inhibits NF-κB signaling and chemokine expression in human astrocytes and in mice'. Together they form a unique fingerprint.

Medicine & Life Sciences